194 related articles for article (PubMed ID: 24692301)
21. Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.
Machado DA; Guzman RM; Xavier RM; Simon JA; Mele L; Pedersen R; Ferdousi T; Koenig AS; Kotak S; Vlahos B
J Clin Rheumatol; 2014 Jan; 20(1):25-33. PubMed ID: 24356474
[TBL] [Abstract][Full Text] [Related]
22. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
Rau R; Schleusser B; Herborn G; Karger T
J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
[TBL] [Abstract][Full Text] [Related]
23. Measurement of erythrocyte methotrexate polyglutamate levels: ready for clinical use in rheumatoid arthritis?
Danila MI; Hughes LB; Brown EE; Morgan SL; Baggott JE; Arnett DK; Bridges SL
Curr Rheumatol Rep; 2010 Oct; 12(5):342-7. PubMed ID: 20665136
[TBL] [Abstract][Full Text] [Related]
24. Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs.
Malysheva OA; Wahle M; Wagner U; Pierer M; Arnold S; Häntzschel H; Baerwald CG
J Rheumatol; 2008 Jun; 35(6):979-85. PubMed ID: 18412314
[TBL] [Abstract][Full Text] [Related]
25. Prediction of the therapeutic response to methotrexate at 24 weeks by methotrexate-polyglutamates concentration in erythrocytes at 8 weeks in patients with rheumatoid arthritis.
Murosaki T; Nagatani K; Sato T; Akiyama Y; Ushijima K; Lefor AK; Fujimura A; Minota S
Mod Rheumatol; 2017 May; 27(3):411-416. PubMed ID: 27435295
[TBL] [Abstract][Full Text] [Related]
26. Methotrexate reduces HbA1c concentration but does not produce chronic accumulation of ZMP in patients with rheumatoid or psoriatic arthritis.
Perdan-Pirkmajer K; Pirkmajer S; Thevis M; Thomas A; Praprotnik S; Hočevar A; Rotar Ž; Gašperšič N; Sodin-Šemrl S; Žibert J; Omersel J; Chibalin AV; Tomšič M; Ambrožič A
Scand J Rheumatol; 2016 Oct; 45(5):347-55. PubMed ID: 26726793
[TBL] [Abstract][Full Text] [Related]
27. Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.
de Rotte MC; de Jong PH; Pluijm SM; Calasan MB; Barendregt PJ; van Zeben D; van der Lubbe PA; de Sonnaville PB; Lindemans J; Hazes JM; de Jonge R
Arthritis Rheum; 2013 Nov; 65(11):2803-13. PubMed ID: 24166792
[TBL] [Abstract][Full Text] [Related]
28. The synergistic efficacy of hydroxychloroquine with methotrexate is accompanied by increased erythrocyte mean corpuscular volume.
Shipa MRA; Yeoh SA; Embleton-Thirsk A; Mukerjee D; Ehrenstein MR
Rheumatology (Oxford); 2022 Feb; 61(2):787-793. PubMed ID: 33944915
[TBL] [Abstract][Full Text] [Related]
29. Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: Pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial.
Goss SL; Klein CE; Jin Z; Locke CS; Rodila RC; Kupper H; Burmester GR; Awni WM
Clin Ther; 2018 Feb; 40(2):309-319. PubMed ID: 29402521
[TBL] [Abstract][Full Text] [Related]
30. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
Hurst S; Kallan MJ; Wolfe FJ; Fries JF; Albert DA
J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722
[TBL] [Abstract][Full Text] [Related]
31. Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients.
Sokka T; Pincus T
J Rheumatol; 2002 Dec; 29(12):2521-4. PubMed ID: 12465145
[TBL] [Abstract][Full Text] [Related]
32. Improvement of High-Density Lipoprotein Function in Patients With Early Rheumatoid Arthritis Treated With Methotrexate Monotherapy or Combination Therapies in a Randomized Controlled Trial.
Charles-Schoeman C; Yin Lee Y; Shahbazian A; Wang X; Elashoff D; Curtis JR; Navarro-Millán I; Yang S; Chen L; Cofield SS; Moreland LW; Paulus H; O'Dell J; Bathon J; Louis Bridges S; Reddy ST
Arthritis Rheumatol; 2017 Jan; 69(1):46-57. PubMed ID: 27483410
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
Gubar' EE; Bochkova AG; Bunchuk NV
Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110
[TBL] [Abstract][Full Text] [Related]
34. The effect of genotype on methotrexate polyglutamate variability in juvenile idiopathic arthritis and association with drug response.
Becker ML; Gaedigk R; van Haandel L; Thomas B; Lasky A; Hoeltzel M; Dai H; Stobaugh J; Leeder JS
Arthritis Rheum; 2011 Jan; 63(1):276-85. PubMed ID: 20954192
[TBL] [Abstract][Full Text] [Related]
35. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR
Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851
[TBL] [Abstract][Full Text] [Related]
36. [Disease-modifying treatment for inflammatory rheumatism in sub-Saharan Africa: outcome at 6 months of 205 Senegalese patients with rheumatoid arthritis].
Ndongo S; Pouye A; Lekpa FK; Bihéhé DM; Tiendrebeogo J; Ndao AC; Ka MM; Moreira Diop T
Med Sante Trop; 2012; 22(4):385-9. PubMed ID: 23352953
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of low-dose glucocorticoids combined with methotrexate and hydroxychloroquine in the treatment of early rheumatoid arthritis: A single-center, randomized, double-blind clinical trial.
Hua L; Du H; Ying M; Wu H; Fan J; Shi X
Medicine (Baltimore); 2020 Jul; 99(27):e20824. PubMed ID: 32629668
[TBL] [Abstract][Full Text] [Related]
38. Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial.
Levitsky A; Erlandsson MC; van Vollenhoven RF; Bokarewa MI
BMC Med; 2015 Sep; 13():247. PubMed ID: 26420684
[TBL] [Abstract][Full Text] [Related]
39. Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use.
Proudman SM; James MJ; Spargo LD; Metcalf RG; Sullivan TR; Rischmueller M; Flabouris K; Wechalekar MD; Lee AT; Cleland LG
Ann Rheum Dis; 2015 Jan; 74(1):89-95. PubMed ID: 24081439
[TBL] [Abstract][Full Text] [Related]
40. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.
O'Dell JR; Leff R; Paulsen G; Haire C; Mallek J; Eckhoff PJ; Fernandez A; Blakely K; Wees S; Stoner J; Hadley S; Felt J; Palmer W; Waytz P; Churchill M; Klassen L; Moore G
Arthritis Rheum; 2002 May; 46(5):1164-70. PubMed ID: 12115219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
